HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenjun Wan Selected Research

mitogen-activated protein kinase kinase kinase 12

12/2021MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenjun Wan Research Topics

Disease

2Neoplasms (Cancer)
10/2021 - 07/2020
1Alzheimer Disease (Alzheimer's Disease)
12/2021
1Triple Negative Breast Neoplasms
10/2021

Drug/Important Bio-Agent (IBA)

1mitogen-activated protein kinase kinase kinase 12IBA
12/2021
1Mitogen-Activated Protein KinasesIBA
12/2021
13-aminobenzeneboronic acidIBA
10/2021
1CatalaseIBA
10/2021
1EnzymesIBA
10/2021
1Lactic Acid (Lactate)FDA LinkGeneric
10/2021
1Small Interfering RNA (siRNA)IBA
10/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2021
1lactate 2-monooxygenaseIBA
10/2021
1FructoseIBA
10/2021
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2020
1AcidsIBA
07/2020
1Histamine (Histamine Dihydrochloride)FDA Link
07/2020
1Antineoplastic Agents (Antineoplastics)IBA
07/2020

Therapy/Procedure

1Therapeutics
10/2021